A chitosan-based hydrogel loaded with fenofibrate for diabetic wound healing

Diabetic wounds represent a common chronic condition, posing significant challenges in the treatment process due to bacterial infections, increased generation of reactive oxygen species (ROS) and exacerbated inflammation. Fenofibrate (FEN) is a clinical medication used for lipid regulation. In this...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biomaterials science 2024-09, Vol.12 (18), p.4682-4694
Hauptverfasser:	Wang, Miaofeng, Deng, Yaping, Huang, Cancan, Javeed, Ansar, Wang, Yifan, Han, Bingnan, Jiang, Guojun
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - chemistry Anti-Inflammatory Agents - pharmacology Biocompatibility Blood vessels Chitosan Chitosan - chemistry Chitosan - pharmacology Diabetes Fenofibrate - administration & dosage Fenofibrate - chemistry Fenofibrate - pharmacology Freeze-thaw Human Umbilical Vein Endothelial Cells - drug effects Humans Hydrogels Hydrogels - administration & dosage Hydrogels - chemistry Hydrogels - pharmacology In vitro methods and tests Inflammatory response Lipids Male Mice Polyvinyl alcohol Polyvinyl Alcohol - chemistry Polyvinyl Alcohol - pharmacology Rats Reactive Oxygen Species - metabolism Scavenging Tumor necrosis factor-TNF Ulcers Wound healing Wound Healing - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!